Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
Add more filters










Publication year range
1.
Molecules ; 29(9)2024 Apr 30.
Article in English | MEDLINE | ID: mdl-38731567

ABSTRACT

A neutral Polygonatum cyrtonema polysaccharide (NPCP) was isolated and purified from Polygonatum cyrtonema by various chromatographic techniques, including DEAE-52 and Sephadex-G100 chromatography. The structure of NPCP was characterized by HPLC, HPGPC, GC-MS, FT-IR, NMR, and SEM. Results showed that NPCP is composed of glucose (55.4%) and galactose (44.6%) with a molecular weight of 3.2 kDa, and the sugar chain of NPCP was →1)-α-D-Glc-(4→1)-ß-D-Gal-(3→. In vitro bioactivity experiments demonstrated that NPCP significantly enhanced macrophages proliferation and phagocytosis while inhibiting the M1 polarization induced by LPS as well as the M2 polarization induced by IL-4 and IL-13 in macrophages. Additionally, NPCP suppressed the secretion of IL-6 and TNF-α in both M1 and M2 cells but promoted the secretion of IL-10. These results suggest that NPCP could serve as an immunomodulatory agent with potential applications in anti-inflammatory therapy.


Subject(s)
Macrophages , Phagocytosis , Polygonatum , Polysaccharides , Macrophages/drug effects , Macrophages/metabolism , Macrophages/immunology , Polygonatum/chemistry , Mice , Polysaccharides/pharmacology , Polysaccharides/chemistry , Polysaccharides/isolation & purification , Animals , Phagocytosis/drug effects , Immunologic Factors/pharmacology , Immunologic Factors/chemistry , Immunologic Factors/isolation & purification , RAW 264.7 Cells , Cytokines/metabolism , Cell Proliferation/drug effects , Immunomodulating Agents/pharmacology , Immunomodulating Agents/chemistry , Immunomodulating Agents/isolation & purification , Molecular Weight
2.
Int J Biol Macromol ; 270(Pt 2): 132222, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38729468

ABSTRACT

Fungal polysaccharides have been explored by many for both structural studies and biological activities, but few studies have been done on the extracellular polysaccharides of Dictyophora rubrovalvata, so a new exopolysaccharide was isolated from Dictyophora rubrovalvata and its structure and its immunological activity were investigated. The crude exopolysaccharide (EPS) was purified by DEAE52 cellulose and Sephadex G-200 to obtain a new acidic polysaccharide (DR-EPS). DR-EPS (2.66 × 103 kDa) was consisted mainly of mannose, glucose, galactose and glucuronic acid with a molar ratio of 1: 0.86: 0.20: 0.01. In addition, DR-EPS increased the phagocytic activity of RAW264.7 cells up to 2.67 times of the blank control group. DR-EPS improved intracellular nucleic acid and glycogen metabolism as observed by AO and PAS staining. DR-EPS(40 µg/mL) promoted NO production up to 30.66 µmol, enhanced acid phosphatase (ACP) and superoxide dismutase (SOD) activities, with activity maxima of 660 U/gprot and 96.27 U/mgprot, respectively, and DR-EPS (160 µg / mL) significantly increased the lysozyme content as 2.73 times of the control group. The good immunological activity of extracellular polysaccharides of Dictyophora rubrovalvata provides directions for the use of fermentation broths.


Subject(s)
Fungal Polysaccharides , Mice , Animals , RAW 264.7 Cells , Fungal Polysaccharides/pharmacology , Fungal Polysaccharides/chemistry , Fungal Polysaccharides/isolation & purification , Nitric Oxide/metabolism , Immunologic Factors/pharmacology , Immunologic Factors/chemistry , Immunologic Factors/isolation & purification , Phagocytosis/drug effects , Immunomodulating Agents/pharmacology , Immunomodulating Agents/chemistry , Immunomodulating Agents/isolation & purification , Superoxide Dismutase/metabolism , Macrophages/drug effects , Macrophages/metabolism , Macrophages/immunology , Acid Phosphatase/metabolism
3.
Molecules ; 29(9)2024 Apr 26.
Article in English | MEDLINE | ID: mdl-38731500

ABSTRACT

A robust, well-functioning immune system is the cornerstone of good health. Various factors may influence the immune system's effectiveness, potentially leading to immune system failure. This review aims to provide an overview of the structure and action of immunomodulators isolated from African medicinal plants. The research was conducted according to PRISMA guidelines. Full-text access research articles published in English up to December 2023, including plant characteristics, isolated phytochemicals, and immuno-modulatory activities, were screened. The chemical structures of the isolated compounds were generated using ChemDraw® (version 12.0.1076), and convergent and distinctive signaling pathways were highlighted. These phytochemicals with demonstrated immunostimulatory activity include alkaloids (berberine, piperine, magnoflorine), polysaccharides (pectin, glucan, acemannan, CALB-4, GMP90-1), glycosides (syringin, cordifolioside, tinocordiside, aucubin), phenolic compounds (ferulic acid, vanillic acid, eupalitin), flavonoids (curcumin, centaurein, kaempferin, luteolin, guajaverin, etc.), terpenoids (oleanolic acid, ursolic acid, betulinic acid, boswellic acids, corosolic acid, nimbidin, andrographolides). These discussed compounds exert their effects through various mechanisms, targeting the modulation of MAPKs, PI3K-Akt, and NF-kB. These mechanisms can support the traditional use of medicinal plants to treat immune-related diseases. The outcomes of this overview are to provoke structural action optimization, to orient research on particular natural chemicals for managing inflammatory, infectious diseases and cancers, or to boost vaccine immunogenicity.


Subject(s)
Phytochemicals , Plants, Medicinal , Plants, Medicinal/chemistry , Phytochemicals/pharmacology , Phytochemicals/chemistry , Humans , Plant Extracts/chemistry , Plant Extracts/pharmacology , Immunomodulating Agents/pharmacology , Immunomodulating Agents/chemistry , Immunomodulating Agents/isolation & purification , Immunologic Factors/pharmacology , Immunologic Factors/chemistry , Immunologic Factors/isolation & purification , Africa , Animals
4.
Molecules ; 29(8)2024 Apr 15.
Article in English | MEDLINE | ID: mdl-38675613

ABSTRACT

Acne is a chronic inflammatory skin disease with a recurring nature that seriously impacts patients' quality of life. Currently, antibiotic resistance has made it less effective in treating acne. However, Paris polyphylla (P. polyphylla) is a valuable medicinal plant with a wide range of chemical components. Of these, P. polyphylla saponins modulate the effects in vivo and in vitro through antibacterial, anti-inflammatory, immunomodulatory, and antioxidant effects. Acne is primarily associated with inflammatory reactions, abnormal sebum function, micro-ecological disorders, hair follicle hyperkeratosis, and, in some patients, immune function. Therefore, the role of P. polyphylla saponins and their values in treating acne is worthy of investigation. Overall, this review first describes the distribution and characteristics of P. polyphylla and the pathogenesis of acne. Then, the potential mechanisms of P. polyphylla saponins in treating acne are listed in detail (reduction in the inflammatory response, antibacterial action, modulation of immune response and antioxidant effects, etc.). In addition, a brief description of the chemical composition of P. polyphylla saponins and its available extraction methods are described. We hope this review can serve as a quick and detailed reference for future studies on their potential acne treatment.


Subject(s)
Acne Vulgaris , Anti-Bacterial Agents , Anti-Inflammatory Agents , Antioxidants , Saponins , Humans , Acne Vulgaris/drug therapy , Antioxidants/pharmacology , Antioxidants/therapeutic use , Antioxidants/chemistry , Saponins/pharmacology , Saponins/chemistry , Saponins/therapeutic use , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/therapeutic use , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/chemistry , Animals , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Immunologic Factors/pharmacology , Immunologic Factors/therapeutic use , Immunologic Factors/chemistry , Immunomodulating Agents/pharmacology , Immunomodulating Agents/chemistry , Immunomodulating Agents/therapeutic use , Immunomodulating Agents/isolation & purification , Melanthiaceae/chemistry , Liliaceae/chemistry
5.
Pharm Biol ; 60(1): 509-524, 2022 Dec.
Article in English | MEDLINE | ID: mdl-35234563

ABSTRACT

CONTEXT: Since the outbreak of SARS-CoV-2, researchers have been working on finding ways to prevent viral entry and pathogenesis. Drug development from naturally-sourced pharmacological constituents may be a fruitful approach to COVID-19 therapy. OBJECTIVE: Most of the published literature has focussed on medicinal plants, while less attention has been given to biodiverse sources such as animal, marine, and microbial products. This review focuses on highlighting natural products and their derivatives that have been evaluated for antiviral, anti-inflammatory, and immunomodulatory properties. METHODS: We searched electronic databases such as PubMed, Scopus, Science Direct and Springer Link to gather raw data from publications up to March 2021, using terms such as 'natural products', marine, micro-organism, and animal, COVID-19. We extracted a number of documented clinical trials of products that were tested in silico, in vitro, and in vivo which paid specific attention to chemical profiles and mechanisms of action. RESULTS: Various classes of flavonoids, 2 polyphenols, peptides and tannins were found, which exhibit inhibitory properties against viral and host proteins, including 3CLpro, PLpro, S, hACE2, and NF-κB, many of which are in different phases of clinical trials. DISCUSSION AND CONCLUSIONS: The synergistic effects of logical combinations with different mechanisms of action emphasizes their value in COVID19 management, such as iota carrageenan nasal spray, ermectin oral drops, omega-3 supplementation, and a quadruple treatment of zinc, quercetin, bromelain, and vitamin C. Though in vivo efficacy of these compounds has yet to be established, these bioproducts are potentially useful in counteracting the effects of SARS-CoV-2.


Subject(s)
Antiviral Agents/pharmacology , Biological Products/pharmacology , COVID-19 Drug Treatment , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/pharmacology , Antiviral Agents/administration & dosage , Antiviral Agents/isolation & purification , Biological Products/isolation & purification , COVID-19/virology , Drug Development/methods , Drug Synergism , Humans , Immunomodulating Agents/administration & dosage , Immunomodulating Agents/isolation & purification , Immunomodulating Agents/pharmacology
6.
J Ethnopharmacol ; 289: 115087, 2022 May 10.
Article in English | MEDLINE | ID: mdl-35143934

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Aerva lanata Linn. (A. lanata) is traditionally used for cough, sore throat and asthma. AIM OF STUDY: The aim of the present study was to investigate the immunomodulatory and anti-inflammatory potentials of A. lanata in allergic asthmatic mice. MATERIALS AND METHODS: BALB/c mice were administered with three different (methanol, n-hexane and ethyl acetate) extracts of A. lanata two weeks after immunization with ovalbumin and continued for 7 days. Inflammatory cells count was estimated in blood and broncho-alveolar lavage fluid (BALF). RT-PCR was used to find out mRNA expression levels of inflammatory mediators. GC-MS analysis was also carried out. RESULTS: Among three extracts of A. lanata, ethyl acetate extract ameliorated (p < 0.001) count of inflammatory cells both blood and BALF remarkably. This study indicated that ethyl acetate extract of A. lanata lowered (p < 0.001) the level of inflammatory modulator TNF-α and IgE antibodies. A. lanata reduced (p < 0.001) interleukin 4, 5, 13 and enhanced (p < 0.001) expression levels of AQP1 and AQP5 in asthmatic mice. GC-MS analysis of ethyl acetate fraction indicated the presence of various anti-oxidant phyto-constituents. The groups treated with A. lanata improved inflammatory, goblet cells hyperplasia scoring and alveolar thickening. CONCLUSIONS: The anti-asthmatic effect of A. lanata might be contributed by the suppression of edema, pro-inflammatory cytokines and IgE antibodies, and elevation of aquaporin expression levels, suggesting future study and clinical trials to propose it as a candidate to treat allergic asthma. The anti-oxidant phytochemicals present in A. lanata might be responsible for such potential.


Subject(s)
Amaranthaceae/chemistry , Anti-Inflammatory Agents/pharmacology , Asthma/drug therapy , Plant Extracts/pharmacology , Animals , Anti-Asthmatic Agents/isolation & purification , Anti-Asthmatic Agents/pharmacology , Anti-Inflammatory Agents/isolation & purification , Antioxidants/isolation & purification , Antioxidants/pharmacology , Cytokines/metabolism , Immunomodulating Agents/isolation & purification , Immunomodulating Agents/pharmacology , Inflammation Mediators/metabolism , Mice , Mice, Inbred BALB C , Ovalbumin , Solvents/chemistry
7.
Molecules ; 27(3)2022 Feb 08.
Article in English | MEDLINE | ID: mdl-35164406

ABSTRACT

Sesquiterpene lactones (SL), characterized by their high prevalence in the Asteraceae family, are one of the major groups of secondary metabolites found in plants. Researchers from distinct research fields, including pharmacology, medicine, and agriculture, are interested in their biological potential. With new SL discovered in the last years, new biological activities have been tested, different action mechanisms (synergistic and/or antagonistic effects), as well as molecular structure-activity relationships described. The review identifies the main sesquiterpene lactones with interconnections between immune responses and anti-inflammatory actions, within different cellular models as well in in vivo studies. Bioaccessibility and bioavailability, as well as molecular structure-activity relationships are addressed. Additionally, plant metabolic engineering, and the impact of sesquiterpene lactone extraction methodologies are presented, with the perspective of biological activity enhancement. Sesquiterpene lactones derivatives are also addressed. This review summarizes the current knowledge regarding the therapeutic potential of sesquiterpene lactones within immune and inflammatory activities, highlighting trends and opportunities for their pharmaceutical/clinical use.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Immunomodulating Agents/pharmacology , Lactones/pharmacology , Sesquiterpenes/pharmacology , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/isolation & purification , Asteraceae/chemistry , Drug Discovery , Humans , Immunomodulating Agents/chemistry , Immunomodulating Agents/isolation & purification , Lactones/chemistry , Lactones/isolation & purification , Sesquiterpenes/chemistry , Sesquiterpenes/isolation & purification
8.
Int J Biol Macromol ; 192: 967-977, 2021 Dec 01.
Article in English | MEDLINE | ID: mdl-34655586

ABSTRACT

Lactarius volemus Fr. is an edible mushroom widely consumed in China. Polysaccharide is an important nutritional component of L. volemus. This research aimed to isolate the polysaccharide from L. volemus and study its structure and bioactivities. A purified polysaccharide was identified and named as LVF-I whose primary structure was proposed considering the comprehensive results of monosaccharide composition, periodate oxidation-smith degradation, methylation analysis, FT-IR and 1D/2D NMR spectroscopy. Then the immunomodulation of LVF-I and its inhibition effect on H1299 and MCF-7 cells were investigated. Results showed that LVF-I (12,894 Da) contained fucose, mannose, glucose and galactose. It had a backbone consisting of →4)-α-D-Glcp-(1→, →6)-ß-D-Manp-(1→, →6)-α-D-Galp-(1 â†’ and →4)-ß-D-Manp-(1→. And its side chains were branched at C2 of →4)-ß-D-Manp-(1 â†’ by →6)-α-D-Galp-(1→, α-D-Glcp-(1→, α-D-Galp-(1 â†’ and α-L-Fucp-(1→. LVF-I (250-1000 µg/mL) could inhibit the proliferation of H1299 and MCF-7 cells, while enhance the proliferative response of splenocyte and the phagocytic ability of RAW264.7. Furthermore, LVF-I (250-1000 µg/mL) significantly induced the secretion of nitric oxide, interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) by up-regulating their mRNA expression in macrophages. These results suggested that LVF-I had the potential to be developed as antitumor or immunomodulatory agents by inhibiting the proliferation of tumor cells and stimulating macrophages-mediated immune responses.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Basidiomycota/chemistry , Fungal Polysaccharides/chemistry , Fungal Polysaccharides/pharmacology , Immunomodulating Agents/chemistry , Immunomodulating Agents/pharmacology , Animals , Antineoplastic Agents/isolation & purification , Cell Line, Tumor , Chemical Phenomena , Cytotoxicity Tests, Immunologic , Fungal Polysaccharides/isolation & purification , Gas Chromatography-Mass Spectrometry , Humans , Immunomodulating Agents/isolation & purification , Magnetic Resonance Spectroscopy , Mice , Molecular Structure , Molecular Weight , RAW 264.7 Cells , Spectroscopy, Fourier Transform Infrared , Structure-Activity Relationship
9.
Biomed Pharmacother ; 144: 112337, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34688080

ABSTRACT

The growing number of deaths related to sepsis has become a major concern for past few years. Sepsis is a complex pathological reactions that is explained by series of host response to microbial insult. The resulted systemic reactions are manifested by early appearance of proinflammatory cytokines leading to hyperinflammatory phase which is followed by septic shock and death of the patient. The present study has revealed that antibiotics are not self-sufficient to control the complex mechanism of sepsis. Moreover prolonged and unnecessary administration of antibiotics may lead to antibiotic resistance to pathogens. In addition to this, immunosuppressive medications are selective and have targeted approach to certain study population. Drugs from herbal origin have shown to possess a mammoth of immunomodulatory potential by suppressing proinflammatory and anti-inflammatory cytokines exhibiting no or minimal unwanted secondary responses. Concomitantly, herbal plants tend to modulate oxidative stress level and haematological imbalance during inflammatory diseased conditions. Natural compounds have gained much attention for the treatment of several clinical complications. Considering the promising responses of medicinal plants with less/no side effects and easy procurement, comprehensive research on herbal plants to treat sepsis should be contemplated.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Immunomodulating Agents/therapeutic use , Phytotherapy , Plant Extracts/therapeutic use , Plants, Medicinal , Sepsis/drug therapy , Animals , Anti-Bacterial Agents/isolation & purification , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/isolation & purification , Antioxidants/isolation & purification , Antioxidants/therapeutic use , Humans , Immunomodulating Agents/isolation & purification , Plant Extracts/isolation & purification , Plants, Medicinal/chemistry , Sepsis/immunology , Sepsis/metabolism , Sepsis/microbiology
10.
Int Immunopharmacol ; 100: 108094, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34508942

ABSTRACT

This work evaluated the immunomodulatory and anti-infective effects of Cratylia mollis lectin (Cramoll) in a model of wound infection induced by S. aureus. Swiss mice were divided into 3 groups (n = 12/group): non-inoculated (Control group); inoculated with S. aureus (Sa group); inoculated with S. aureus and treated with Cramoll (Sa + Cramoll group). In each animal, one lesion (64 mm2) was induced on the back and contaminated with S. aureus (~4.0 × 106 CFU/wound). The treatment with Cramoll (5 µg/animal/day) started 1-day post-infection (dpi) and extended for 10 days. Clinical parameters (wound size, inflammatory aspects, etc.) were daily recorded; while cytokines levels, bacterial load and histological aspects were determined in the cutaneous tissue at 4th dpi or 11th dpi. The mice infected with S. aureus exhibited a delay in wound contraction and the highest inflammatory scores. These effects were impaired by the treatment with Cramoll which reduced the release of key inflammatory mediators (TNF-α, NO, VEGF) and the bacterial load at wound tissue. Histological evaluations showed a restauration of skin structures in the animals treated with Cramoll. Taken together, these results provide more insights about the healing and immunomodulatory properties of Cramoll and suggest this lectin as a lead compound for treatment of wound infection.


Subject(s)
Anti-Bacterial Agents/pharmacology , Fabaceae , Immunomodulating Agents/pharmacology , Plant Lectins/pharmacology , Staphylococcal Infections/prevention & control , Staphylococcus aureus/drug effects , Wound Infection/prevention & control , Animals , Anti-Bacterial Agents/isolation & purification , Bacterial Load , Disease Models, Animal , Fabaceae/chemistry , Host-Pathogen Interactions , Immunomodulating Agents/isolation & purification , Mice , Nitric Oxide/metabolism , Plant Lectins/isolation & purification , Staphylococcal Infections/immunology , Staphylococcal Infections/metabolism , Staphylococcal Infections/microbiology , Staphylococcus aureus/growth & development , Tumor Necrosis Factor-alpha/metabolism , Vascular Endothelial Growth Factor A/metabolism , Wound Healing/drug effects , Wound Infection/immunology , Wound Infection/metabolism , Wound Infection/microbiology
11.
Naunyn Schmiedebergs Arch Pharmacol ; 394(11): 2167-2185, 2021 11.
Article in English | MEDLINE | ID: mdl-34542667

ABSTRACT

The link between diabetes and cognitive dysfunction has been reported in many recent articles. There is currently no disease-modifying treatment available for cognitive impairment. Boswellia serrata (B. serrata) is used traditionally to treat chronic inflammatory diseases such as type 2 diabetes (T2D), insulin resistance (IR), and Alzheimer's disease (AD). This review aims to highlight current research on the potential use of boswellic acids (BAs)/B. serrata extract in T2D and AD. We reviewed the published information through June 2021. Studies have been collected through a search on online electronic databases (Academic libraries as PubMed, Scopus, Web of Science, and Egyptian Knowledge Bank). Accumulating evidence in preclinical and small human clinical studies has indicated that BAs/B. serrata extract has potential therapeutic effect in T2D and AD. According to most of the authors, the potential therapeutic effects of BAs/B. serrata extract in T2D and AD can be attributed to immunomodulatory, anti-inflammatory, antioxidant activity, and elimination of the senescent cells. BAs/B. serrata extract may act by inhibiting the IκB kinase/nuclear transcription factor-κB (IKK/NF-κB) signaling pathway and increasing the formation of selective anti-inflammatory LOX-isoform modulators. In conclusion, BAs/B. serrata extract may have positive therapeutic effects in prevention and therapy of T2D and AD. However, more randomized controlled trials with effective, large populations are needed to show a definitive conclusion about therapeutic efficacy of BAs/B. serrata extract in T2D and AD.


Subject(s)
Boswellia/chemistry , Plant Extracts/pharmacology , Triterpenes/pharmacology , Alzheimer Disease/drug therapy , Alzheimer Disease/physiopathology , Alzheimer Disease/prevention & control , Animals , Anti-Inflammatory Agents, Non-Steroidal/isolation & purification , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antioxidants/isolation & purification , Antioxidants/pharmacology , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/physiopathology , Diabetes Mellitus, Type 2/prevention & control , Humans , Immunomodulating Agents/isolation & purification , Immunomodulating Agents/pharmacology , Randomized Controlled Trials as Topic , Triterpenes/isolation & purification
12.
Biomed Pharmacother ; 143: 112148, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34560553

ABSTRACT

Ulcerative colitis (UC) is a gastrointestinal inflammatory disease with a multifactorial pathophysiology. This study aims to investigate the immunomodulatory effect of Portulaca oleracea leaf ethanolic extract (POE) on acetic acid (AA)-induced UC in mice. Experimental animals received oral doses of POE (200 mg/kg for 7 days) after an induction of colitis by intrarectal AA administration. In mice with AA-induced UC treated with POE, the results revealed a significant modulation in body weight and colon length. Moreover, treatment with POE downregulated the interleukin 1, 6, and 17, tumor necrosis factor-alpha, gamma interferon, and nuclear factor-kappa B levels compared with the colitis group. Furthermore, POE markedly inhibited histological damage, decreased myeloperoxidase activity and reduced fecal calprotectin level compared with the colitis group. These data are consistent with the reduction in total bacterial content in the colon. Taken together, treatment with POE may reduce colonic inflammation by alleviating the immune response and inhibiting the severity of colitis. The HPLC analysis of POE resulted in the identification of seven medicinal compounds comprising two phenolic acids (ferulic and caffeic acids) and five flavonoids (kaempferol, quercetin, rutin, narenginin and hesperidin). Subsequent analysis of POE by GC-MS revealed ten phytocomponents; the major percentages were hexadecenoic acid, methyl ester (29.8119%), α-linolenic acid (25.8431%), 16-octadecenoic acid, methyl ester (15.1578%) and α-tocopherol (10.7848%). Delta-lactams and alkanes were the minor components. Such natural plant-derived substances and their probable synergistic action appear to contribute to a promising therapeutic protocol for colitis.


Subject(s)
Colitis/drug therapy , Immunomodulating Agents/pharmacology , Phytochemicals/pharmacology , Plant Extracts/pharmacology , Portulaca , Animals , Colitis/immunology , Colitis/metabolism , Colitis/microbiology , Cytokines/metabolism , Disease Models, Animal , Gastrointestinal Microbiome , Immunomodulating Agents/isolation & purification , Inflammation Mediators/metabolism , Leukocyte L1 Antigen Complex/metabolism , Male , Mice , NF-kappa B/metabolism , Peroxidase/metabolism , Phytochemicals/isolation & purification , Plant Extracts/isolation & purification , Plant Leaves , Portulaca/chemistry
13.
Biomed Pharmacother ; 143: 112177, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34555627

ABSTRACT

The study aimed, by integrating transcriptomics and metabolomics, to reveal novel biomarkers caused by overdosed acetaminophen (APAP) and liver protection substances procured by pre-administration of ginseng shoots extract (GSE). Totally 4918 genes and 127 metabolites were identified as differentially expressed genes and differential metabolites, respectively. According to KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment, such pathways as primary bile acid biosynthesis, bile secretion, retinol metabolism, histidine and several other amino-related metabolism were significantly altered by GSE and disturbed by subsequent overdosed APAP at the transcriptomic as well as metabolomic levels. Fifteen key biomarker metabolites related to these pathways were up-regulated in APAP-treated vs GSE-pretreated liver tissues, and were reported exerting anti-oxidant, anti-inflammatory, anti-apoptotic and/or immunomodulate functions, three of which even possessed direct hepatoprotection effects. Twenty five vital unigenes modulating these metabolites were further verified by correlation analysis and expression levels of fifteen of them were examined by qRT-PCR. Our findings indicate that GSE may be an effective dietary supplement for preventing the liver damage caused by the overdosed APAP.


Subject(s)
Chemical and Drug Induced Liver Injury/prevention & control , Gene Expression Profiling , Liver/drug effects , Metabolome , Metabolomics , Panax , Plant Extracts/pharmacology , Transcriptome , Acetaminophen , Amino Acids/metabolism , Animals , Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/pharmacology , Antioxidants/isolation & purification , Antioxidants/pharmacology , Apoptosis/drug effects , Bile Acids and Salts/metabolism , Biomarkers/metabolism , Chemical and Drug Induced Liver Injury/genetics , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Disease Models, Animal , Drug Overdose , Immunomodulating Agents/isolation & purification , Immunomodulating Agents/pharmacology , Inflammation Mediators/metabolism , Liver/metabolism , Liver/pathology , Mice , Oxidative Stress/drug effects , Panax/chemistry , Plant Extracts/isolation & purification , Plant Shoots , Steam , Vitamin A/metabolism
14.
Inflammopharmacology ; 29(5): 1399-1412, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34510276

ABSTRACT

BACKGROUND: Mesenchymal stem cells-derived adipose tissue (AT-MSCs) are recognized for the treatment of inflammatory diseases including multiple sclerosis (MS). Hypericum perforatum (HP) is an anti-inflammatory pharmaceutical plant with bioactive compounds. Plant tissue culture is a technique to improve desired pharmacological potential. The aim of this study was to compare the anti-inflammatory and proliferative effects of callus with field-growing plant extracts of HP on AT-MSCs derived from MS patients. MATERIALS AND METHODS: AT-MSCs were isolated and characterized. HP callus was prepared and exposure to light spectrum (blue, red, blue-red, and control). Total phenols, flavonoids, and hypericin of HP callus and plant extracts were measured. The effects of HP extracts concentrations on proliferation were evaluated by MTT assay. Co-culture of AT-MSCs: PBMCs were challenged by HP plant and callus extracts, and Tregs percentage was assessed by flow cytometry. RESULTS: Identification of MSCs was performed. Data showed that blue light could stimulate total phenols, flavonoids, and hypericin. MTT test demonstrated that plant extract in concentrations (0.03, 1.2, 2.5 and 10 µg/ml) and HP callus extract in 10 µg/ml significantly increased. Both HP extracts lead to an increase in Tregs percentage in all concentrations. In particular, a comparison between HP plant and callus extracts revealed that Tregs enhanced 3-fold more than control groups in the concentration of 10 µg/ml callus. CONCLUSIONS: High concentrations of HP extracts showed effectiveness on AT-MSCs proliferation and immunomodulatory properties with a certain consequence in callus extract. HP extracts may be considered as supplementary treatments for the patients who receiving MSCs transplantation.


Subject(s)
Hypericum/chemistry , Mesenchymal Stem Cells/drug effects , Multiple Sclerosis/drug therapy , Plant Extracts/pharmacology , Adipose Tissue/cytology , Adult , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/pharmacology , Cell Proliferation/drug effects , Coculture Techniques , Dose-Response Relationship, Drug , Female , Humans , Immunomodulating Agents/administration & dosage , Immunomodulating Agents/isolation & purification , Immunomodulating Agents/pharmacology , Mesenchymal Stem Cells/cytology , Multiple Sclerosis/immunology , Plant Extracts/administration & dosage
15.
Int J Biol Macromol ; 187: 931-938, 2021 Sep 30.
Article in English | MEDLINE | ID: mdl-34363824

ABSTRACT

The in vitro and in vivo immunoregulatory activity of a water-soluble sulfated fucan AL1-1 from the sea cucumber A. leucoprocta was elucidated. In vitro experiments showed that AL1-1 up-regulated immunostimulatory activities in RAW264.7 cells and that it could successfully promote ROS production and phagocytic activity, increase secretion levels of iNOS, and induce the production of considerable amounts of cytokines (TNF-α, IL-6, IL-1ß and IL-12). We found that toll-like receptor 4 (TLR4) was mainly involved in AL1-1 mediated macrophage activation. AL1-1's in vivo immunomodulatory activity on cyclophosphamide (CY)-treated mice was investigated and it was shown that it could strongly enhance Sig A levels, promote the total antioxidant capacity (T-AOC), and reduce malondialdehyde (MDA) level in the intestine. It could also increase activities of superoxidase dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-PX). These results demonstrate that AL1-1 has a significant effect on enhancing in vivo and in vitro immune response.


Subject(s)
Immunity, Mucosal/drug effects , Immunomodulating Agents/pharmacology , Intestinal Mucosa/drug effects , Macrophage Activation/drug effects , Macrophages/drug effects , Polysaccharides/pharmacology , Sea Cucumbers , Animals , Antioxidants/metabolism , Cytokines/metabolism , Female , Free Radical Scavengers/isolation & purification , Free Radical Scavengers/pharmacology , Immunoglobulin A, Secretory/metabolism , Immunomodulating Agents/isolation & purification , Intestinal Mucosa/immunology , Intestinal Mucosa/metabolism , Macrophages/immunology , Macrophages/metabolism , Mice , Mice, Inbred ICR , Nitric Oxide Synthase Type II/metabolism , Phagocytosis/drug effects , Polysaccharides/isolation & purification , RAW 264.7 Cells , Reactive Oxygen Species/metabolism , Sea Cucumbers/chemistry , Toll-Like Receptor 4/metabolism
16.
Inflammopharmacology ; 29(4): 1201-1210, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34241784

ABSTRACT

Marine sponges and their associated microbiota are multicellular animals known to produce metabolites with interesting pharmacological properties playing a pivotal role against a plethora of pathologic disorders such as inflammation, cancer and infections. Characellide A and B belong to a novel class of glycolipopeptides isolated from the deep sea marine sponge Characella pachastrelloides. In this study, we have evaluated the effects of characellide A and B on cytokine and chemokine release from human peripheral blood mononuclear cells (PBMC). Characellide A induces a concentration- and time-dependent CXCL8, IL-6 and TNF-α release from PBMC. This production is mediated by the induction of gene transcription. Moreover, cytokine/chemokine release induced by characellide A from PBMC is CD1d-dependent because a CD1d antagonist, 1,2-bis(diphenylphosphino)ethane [DPPE]-polyethylene glycolmonomethylether [PEG], specifically inhibits characellide A-induced activation of PBMC. In conclusion, characellide A is a novel modulator of adaptative/innate immune responses. Further studies are needed to understand its potential pharmacological application.


Subject(s)
Biological Factors/pharmacology , Immunomodulating Agents/pharmacology , Inflammation Mediators/metabolism , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/metabolism , Porifera , Animals , Biological Factors/isolation & purification , Dose-Response Relationship, Drug , Humans , Immunomodulating Agents/isolation & purification , Immunomodulation/drug effects , Immunomodulation/physiology , Inflammation Mediators/agonists , Inflammation Mediators/immunology , Leukocytes, Mononuclear/immunology
17.
Viruses ; 13(7)2021 06 28.
Article in English | MEDLINE | ID: mdl-34203182

ABSTRACT

Developing broad-spectrum antiviral drugs remains an important issue as viral infections continue to threaten public health. Host-directed therapy is a method that focuses on potential targets in host cells or the body, instead of viral proteins. Its antiviral effects are achieved by disturbing the life cycles of pathogens or modulating immunity. In this review, we focus on the development of broad-spectrum antiviral drugs that enhance the immune response. Some natural products present antiviral effects mediated by enhancing immunity, and their structures and mechanisms are summarized here. Natural products with immunomodulatory effects are also discussed, although their antiviral effects remain unknown. Given the power of immunity and the feasibility of host-directed therapy, we argue that both of these categories of natural products provide clues that may be beneficial for the discovery of broad-spectrum antiviral drugs.


Subject(s)
Antiviral Agents/pharmacology , Biological Products/pharmacology , Drug Discovery , Immunomodulating Agents/pharmacology , Viruses/drug effects , Animals , Antiviral Agents/isolation & purification , Antiviral Agents/therapeutic use , Biological Products/chemistry , Humans , Immunomodulating Agents/isolation & purification , Mice , Virus Diseases/drug therapy , Virus Replication/drug effects
18.
Mar Drugs ; 19(6)2021 Jun 15.
Article in English | MEDLINE | ID: mdl-34203925

ABSTRACT

The aim of this study was to evaluate the effects of ingesting fucoidan derived from Okinawa mozuku (Cladosiphon okamuranus) on natural killer (NK) cell activity and to assess its safety in healthy adults via a randomized, double-blind, parallel-group, placebo-controlled pilot study. Subjects were randomly divided into two groups-a placebo group (ingesting citric acid, sucralose, and caramel beverages; n = 20; 45.5 ± 7.8 years (mean ± standard deviation)) and a fucoidan group (3.0 g/day from beverages; n = 20; 47.0 ± 7.6 years); after 12 weeks, blood, biochemical, and immunological tests were performed. Clinically adverse events were not observed in any of the tests during the study period. In addition, adverse events due to the test food were not observed. In the immunological tests, NK cell activity was significantly enhanced at 8 weeks in the fucoidan group, compared to before ingestion (0 weeks). In addition, a significantly enhanced NK cell activity was observed in male subjects at 8 weeks, compared with the placebo group. These results confirm that Okinawa mozuku-derived fucoidan enhances NK cell activity and suggest that it is a safe food material.


Subject(s)
Biological Products/pharmacology , Immunomodulating Agents/pharmacology , Killer Cells, Natural/drug effects , Phaeophyceae/chemistry , Polysaccharides/pharmacology , Adult , Aged , Biological Products/isolation & purification , Biomarkers/blood , Double-Blind Method , Female , Healthy Volunteers , Humans , Immunomodulating Agents/isolation & purification , Killer Cells, Natural/immunology , Male , Middle Aged , Pilot Projects , Polysaccharides/isolation & purification
19.
Int J Biol Macromol ; 187: 769-779, 2021 Sep 30.
Article in English | MEDLINE | ID: mdl-34197853

ABSTRACT

Ganoderma lucidum (G. lucidum) polysaccharides and triterpenoids are the major bioactive compounds and have been used as traditional medicine for ancient times. Massive demands of G. lucidum have fascinated the researchers towards its application as functional food, nutraceutical and modern medicine owing to wide range of application in various diseases include immunomodulators, anticancer, antiviral, antioxidant, cardioprotective, hepatoprotective. G. lucidum polysaccharides exhibit immunomodulatory properties through boosting the action of antigen-presenting cells, mononuclear phagocyte system, along with humoral and cellular immunity. ß-Glucans isolated from G. lucidum are anticipated to produce an immune response through pathogen associated molecular patterns (PAMPs). ß-Glucans after binding with dectin-1 receptor present on different cells include macrophages, monocytes, dendritic cells and neutrophils produce signal transduction that lead to trigger the mitogen-activated protein kinases (MAPKs), T cells and Nuclear factor-κB (NF-κB) that refer to cytokines production and contributing to immune response. While triterpenoids produce antiviral effects through inhibiting various enzymes like neuraminidase, HIV-protease, DENV2 NS2B-NS3 protease and HSV multiplication. Polysaccharides and triterpenoids adjunct to other drugs exhibit potential action in prevention and treatment of various diseases. Immunomodulators and antiviral properties of this mushroom could be a potential source to overcome this current pandemic outbreak.


Subject(s)
Antiviral Agents/pharmacology , Immune System/drug effects , Immunomodulating Agents/pharmacology , Reishi , Triterpenes/pharmacology , Virus Diseases/drug therapy , beta-Glucans/pharmacology , Animals , Antiviral Agents/isolation & purification , Host-Pathogen Interactions , Humans , Immune System/immunology , Immune System/metabolism , Immunomodulating Agents/isolation & purification , Molecular Structure , Reishi/chemistry , Signal Transduction , Structure-Activity Relationship , Triterpenes/isolation & purification , Virus Diseases/immunology , Virus Diseases/metabolism , Virus Diseases/virology , beta-Glucans/isolation & purification
20.
Int J Biol Macromol ; 186: 385-395, 2021 Sep 01.
Article in English | MEDLINE | ID: mdl-34197855

ABSTRACT

The structures and immunomodulatory activities of two polysaccharides (SDH-WA and SDH-0.2A) from Rehmanniae Radix Praeparata (RRP) were investigated. RRP crude polysaccharide was obtained by water extraction and purified. Ion chromatography, high-performance gel permeation chromatography, Fourier-transform infrared spectroscopy, methylation analysis, gas chromatography-mass spectrometry, and nuclear magnetic resonance were used to characterize the polysaccharides. The main chain of SDH-WA was →6)-α-D-Galp-(1→6)-α-D-Galp-(1→5)-α-L-Araf-(1→3,5)-α-L-Araf-(1→, terminal sugar residue α-L-Araf-(1→ linked to residue →3,5)-α-L-Araf-(1→ on the main chain by an O-3 bond. The other two terminal sugar residues α-D-Galp-(1→ and →6)-ß-D-Galp were linked to the end of the main chain. The main chain of SDH-0.2A was →2,4)-α-L-Rhap-(1→4)-α-D-GalpA-(1→. Three branched chains α-D-Galp-(1→6)-α-D-Galp-(1→5)-α-L-Araf-(1→3,5)-α-L-Araf-(1→, →3,6)-ß-D-Galp-(1→5)-α-L-Araf-(1→, and →4)-ß-D-Galp-(1→5)-α-L-Araf-(1→ were linked to the main chain residue →2,4)-α-L-Rhap-(1→ by an O-2 bond. Three terminal sugar residues α-D-Galp-(1→, α-L-Araf-(1→, and →6)-ß-D-Galp were linked to the end of the chain. Both polysaccharides showed no cytotoxic effects on and significantly promoted the phagocytic activity of RAW264.7 cells. They dose-dependently improved lysozyme activity and stimulated the production of TNF-α and IL-6 by RAW264.7 cells, but attenuated the secretion of lysozymes, TNF-α, IL-6, IL-1ß, and nitric oxide by lipopolysaccharide-induced RAW264.7 cells. The present studies suggest that PRR polysaccharide is a valuable source with immunomodulating.


Subject(s)
Immunomodulating Agents/pharmacology , Macrophages/drug effects , Plant Extracts , Polysaccharides/pharmacology , Rehmannia , Animals , Immunomodulating Agents/isolation & purification , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Macrophages/immunology , Macrophages/metabolism , Mice , Molecular Structure , Muramidase/metabolism , Nitric Oxide/metabolism , Phagocytosis/drug effects , Plant Extracts/chemistry , Polysaccharides/isolation & purification , RAW 264.7 Cells , Rehmannia/chemistry , Structure-Activity Relationship , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...